Cite

HARVARD Citation

    Aalinkeel, R. et al. (2016). Nanotherapy silencing the interleukin‐8 gene produces regression of prostate cancer by inhibition of angiogenesis. Immunology. 148 (4), pp. 387-406. [Online]. 
  
Back to record